AbbVie (ABBV) Other Non-Current Assets (2012 - 2026)

AbbVie (ABBV) has 15 years of Other Non-Current Assets data on file, last reported at $10.5 billion in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $10.5 billion, up 14.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 billion (up 14.62% YoY), and the FY2025 annual result was $10.7 billion, up 17.27% from the prior year.
• Other Non-Current Assets slipped to $10.5 billion in Q1 2026 per ABBV's latest filing, from $10.7 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $10.7 billion in Q4 2025 and troughed at $5.0 billion in Q2 2022.
• A 5-year average of $7.9 billion and a median of $8.5 billion in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 56.33% in 2024, then rose 1.38% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $5.6 billion in 2022, then surged by 52.81% to $8.5 billion in 2023, then gained by 7.39% to $9.1 billion in 2024, then advanced by 17.27% to $10.7 billion in 2025, then slipped by 1.73% to $10.5 billion in 2026.
• Business Quant data shows ABBV's Other Non-Current Assets at $10.5 billion in Q1 2026, $10.7 billion in Q4 2025, and $9.6 billion in Q3 2025.